Neuro65/AOCN2024

Presentation information

Print

Japanese Poster Session

Japanese

[Pj-013] Japanese Poster Session 013「Neuroimmunology: MS (Disease modifying drug )」

Wed. May 29, 2024 5:20 PM - 6:40 PM Poster (Hall E, E Block, B2F, TIF)

Chair(s): Masaaki Niino (Department of Clinical Research, NHO Hokkaido Medical Center, Japan)

[Pj-013-2] PML in a MS patient treated with natalizumab every 6 weeks for 3 years after fingolimod for 8 years

Masami Tanaka1,2, Kazuo Nakamichi3 (1.MS Center, Kyoto Min-Iren Chuo Hospital, Japan, 2.Department of Neurology, Josai Hospital, Japan, 3.Department of Virology 1, National Institute of Infectious Diseases, Japan)

Abstract password authentication.
You can find the password on page 15 of the program book.

Password